Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine (Q47356431)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2004

Language	Label	Description	Also known as
English	Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine	scientific article published in June 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

influenza vaccine

0 references

author name string

Evgenia Greenbaum

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Dan Engelhard

2

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Reuven Levy

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Miriam Schlezinger

4

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Avraham Morag

5

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Zichria Zakay-Rones

6

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

22

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

20

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

2566-2577

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Enteric immunization of mice against influenza with recombinant vaccinia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Developments in mucosal influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Secretory antibody following oral influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Immunostimulating reconstituted influenza virosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Liposomes and ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Recommendations for the use of inactivated influenza vaccines and other preventive measures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Antibody response to influenza immunization in patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Influenza and the work of the World Health Organization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Age-dependent antibody response in mice and humans following oral influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Cold-attenuated live influenza vaccines, a risk-benefit assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Reduction in mortality associated with influenza vaccine during 1989-90 epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.12.018

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47356431&oldid=2153312320"